% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Penkert:168525,
author = {J. Penkert and A. Märtens and M. Seifert and B. Auber and
K. Derlin and U. Hille-Betz and P. Hörmann and N. Klopp and
J. Prokein and L. Schlicker$^*$ and F. Wacker and H.
Wallaschek and B. Schlegelberger and K. Hiller and T.
Ripperger and T. Illig},
title = {{P}lasma {M}etabolome {S}ignature {I}ndicative of {BRCA}1
{G}ermline {S}tatus {I}ndependent of {C}ancer {I}ncidence.},
journal = {Frontiers in oncology},
volume = {11},
issn = {2234-943X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2021-00957},
pages = {627217},
year = {2021},
note = {Division of Tumour Metabolism and Microenvironment, German
Cancer Research Center (DKFZ), Heidelberg, Germany.},
abstract = {Individuals carrying a pathogenic germline variant in the
breast cancer predisposition gene BRCA1 (gBRCA1+) are prone
to developing breast cancer. Apart from its well-known role
in DNA repair, BRCA1 has been shown to powerfully impact
cellular metabolism. While, in general, metabolic
reprogramming was named a hallmark of cancer, disrupted
metabolism has also been suggested to drive cancer cell
evolution and malignant transformation by critically
altering microenvironmental tissue integrity. Systemic
metabolic effects induced by germline variants in cancer
predisposition genes have been demonstrated before. Whether
or not systemic metabolic alterations exist in gBRCA1+
individuals independent of cancer incidence has not been
investigated yet. We therefore profiled the plasma
metabolome of 72 gBRCA1+ women and 72 age-matched female
controls, none of whom (carriers and non-carriers) had a
prior cancer diagnosis and all of whom were cancer-free
during the follow-up period. We detected one single
metabolite, pyruvate, and two metabolite ratios involving
pyruvate, lactate, and a metabolite of yet unknown
structure, significantly altered between the two cohorts. A
machine learning signature of metabolite ratios was able to
correctly distinguish between gBRCA1+ and controls in
$~82\%.$ The results of this study point to innate systemic
metabolic differences in gBRCA1+ women independent of cancer
incidence and raise the question as to whether or not
constitutional alterations in energy metabolism may be
involved in the etiology of BRCA1-associated breast cancer.},
keywords = {BRCA1 germline mutation (Other) / HIF1 alpha (Other) / NAD+
balance (Other) / aerobic glycolysis (Other) / breast cancer
(Other) / energy metabolism (Other) / lactate (Other) /
plasma metabolome (Other)},
cin = {A410},
ddc = {610},
cid = {I:(DE-He78)A410-20160331},
pnm = {311 - Zellbiologie und Tumorbiologie (POF4-311)},
pid = {G:(DE-HGF)POF4-311},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33898308},
pmc = {pmc:PMC8058469},
doi = {10.3389/fonc.2021.627217},
url = {https://inrepo02.dkfz.de/record/168525},
}